Provention Bio, Inc.

Provention Bio, Inc.verified

PRVB

Price:

$24.98

Market Cap:

$2.38B

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and c...[Read more]

Industry

Biotechnology

IPO Date

2018-07-24

Stock Exchange

NASDAQ

Ticker

PRVB

The PE Ratio as of June 2024 (TTM) for Provention Bio, Inc. (PRVB) is -16.43

According to Provention Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.43. This represents a change of 293.09% compared to the average of -4.18 of the last 4 quarters.

Provention Bio, Inc. (PRVB) Historical PE Ratio (quarterly & annually)

How has PRVB PE Ratio performed in the past?

The mean historical PE Ratio of Provention Bio, Inc. over the last ten years is -7.54. The current -16.43 PE Ratio has changed 21.69% with respect to the historical average. Over the past ten years (40 quarters), PRVB's PE Ratio was at its highest in in the December 2018 quarter at -1.75. The PE Ratio was at its lowest in in the March 2017 quarter at -947.73.

Quarterly (TTM)
Annual

Average

-7.54

Median

-6.95

Minimum

-17.84

Maximum

0

Provention Bio, Inc. (PRVB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Provention Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 859.09%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -17.84

Quarterly (TTM)
Annual
YearPE RatioChange
2022-6.95124.42%
2021-3.10-65.62%
2020-9.01-37.35%
2019-14.39859.09%
2018-1.50-91.59%
2017-17.84-Infinity%

Provention Bio, Inc. (PRVB) Average PE Ratio

How has PRVB PE Ratio performed in the past?

The current PE Ratio of Provention Bio, Inc. (PRVB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-6.36

5-year avg

-6.99

10-year avg

-7.54

Provention Bio, Inc. (PRVB) PE Ratio vs. Peers

How is PRVB’s PE Ratio compared to its peers?

Provention Bio, Inc.’s PE Ratio is greater than IVERIC bio, Inc. (-33.43), less than Immunovant, Inc. (-14.68), less than Akero Therapeutics, Inc. (-7.33), less than Madrigal Pharmaceuticals, Inc. (-12.43), less than Apellis Pharmaceuticals, Inc. (-11.81), less than Prometheus Biosciences, Inc. (0), greater than Viking Therapeutics, Inc. (-81.93), greater than Intercept Pharmaceuticals, Inc. (-55.90), less than Terns Pharmaceuticals, Inc. (-13.55), less than Reata Pharmaceuticals, Inc. (-6.02), greater than BioLineRx Ltd. (-89.36), less than Ardelyx, Inc. (-0.91), greater than Lexicon Pharmaceuticals, Inc. (-21.07), less than Seres Therapeutics, Inc. (-2.24), less than ImmunityBio, Inc. (-1.26), less than null (-6.98),

Build a custom stock screener for Provention Bio, Inc. (PRVB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Provention Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Provention Bio, Inc. (PRVB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Provention Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Provention Bio, Inc.'s PE Ratio?

How is the PE Ratio calculated for Provention Bio, Inc. (PRVB)?

What is the highest PE Ratio for Provention Bio, Inc. (PRVB)?

What is the 3-year average PE Ratio for Provention Bio, Inc. (PRVB)?

What is the 5-year average PE Ratio for Provention Bio, Inc. (PRVB)?

How does the current PE Ratio for Provention Bio, Inc. (PRVB) compare to its historical average?